March 27th Options Now Available For Intuit (INTU)

The article outlines two INTU options strategies: selling a $440 put (bid $27.50) which nets a $412.50 effective cost basis versus the $447.15 market price and has a 58% chance to expire worthless, implying a 6.25% return (45.66% annualized) on cash committed; and selling a $450 call (bid $31.00) as a covered call against shares bought at $447.15, which would yield 7.57% if called at the March 27 expiration and has a 47% chance to expire worthless (6.93% YieldBoost, 50.65% annualized). Implied vols are ~54% (put) and 53% (call) versus a trailing 12‑month volatility of 35%, making these income-oriented option plays that may appeal to investors seeking yield-alternative entry/exit mechanics on INTU rather than directional stock exposure.

Analysis

Market structure: The option market is signaling elevated risk premia in INTU (IV ~53–54% vs realized 35%), which benefits volatility sellers (income strategies) and market makers collecting rich premium while penalizing directional buyers who pay expensive calls. Short-dated premium (to Mar 27) prices a ~47–58% chance of OTM outcomes, implying asymmetric near-term payoffs favoring cash-secured puts or buy-write strategies if you accept assignment at $440–$450.

Risk assessment: Tail risks include a >15% downside from macro shock or a company-specific event (missed guidance, regulatory change in tax filing/tax software) that would turn a cash-secured put into an unwanted $44k equity exposure; implied odds are non-trivial given current IV. Immediate horizon (days–weeks): option theta is a friend to sellers; short-term event risk (earnings/IRS rule changes) within 30–60 days should be screened. Long-term (quarters+): competitive share-loss to Xero/Intuit’s pricing power erosion are medium-probability structural risks.

Trade implications: Prefer premium capture trades: sell-to-open cash-secured 440 puts or buy-write at 450 (collect $2,750 or $3,100 per contract) with position sizing capped (1–3% portfolio, max 2 contracts per $1mm AUM) and defined assignment tolerance. If you want volatility exposure, implement calendar or diagonal sells (sell front-month, buy 3–6 month) to harvest mean-reversion in IV. Consider relative-value: long INTU equity + short IGV (software ETF) to isolate company-specific upside while hedging sector drawdowns.

Contrarian angles: Consensus assumes persistent high IV — history shows IV mean-reverts post-expiration/earnings; selling front-month vs buying back-month can harvest >40–50% annualized carry (as example YieldBoost suggests). Risk of being assigned or of a sudden IV gap remains; avoid aggressive selling within 10 trading days of any catalyst and size positions so a 10–15% adverse move is tolerable without forced liquidation.

Key Decisions for Investors

• Sell-to-open cash-secured INTU $440 put (1 contract = obligation to buy 100 shares at $44,000) and collect $2,750 premium; position size = 1% portfolio per contract (e.g., $10k premium capacity per $1M AUM), max 2 contracts; set assignment tolerance to buy only if you intend to hold to 6–12 months and place mental stop/roll if INTU trades < $400 (≈10.5% below strike).
• Buy-write INTU at $447.15 and sell $450 call Mar-27; collect ~$3,100; target total return if called = ~7.6% to Mar-27; cap exposure to 1–2% portfolio, and plan to roll up-and-out if stock >$460 or buy back call if IV drops >15 pts from current to lock profits.
• Implement a front-month sell / back-month buy diagonal: sell Mar $450 calls and buy Jun $450 calls (1:1) to capture elevated front IV (≈53%) vs back IV; use for 0.5–1% portfolio exposure and close/adjust if IV term structure inverts or before any known catalyst within 14 days.
• Relative value: Go long INTU equity (2% portfolio) and short IGV (software ETF) equal dollar (1:1) to isolate company-specific strength; reassess in 3 months and trim if spread narrows <5% or macro beta divergence exceeds 8%.
• Avoid initiating premium-selling positions within 10 trading days of confirmed earnings/major IRS or regulatory announcements; if such a catalyst is scheduled inside 30 days, reduce size by 50% or shift to longer-dated puts/calls to lower gamma risk.